Assignee
AJAX THERAPEUTICS INC
US·5 granted patents·4 pending applications·6 citations·filing 2021–2025
Top patents by PatentIndex Score
9 records- 0192US11691963B26-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitorsAJAX THERAPEUTICS INC·Filed 2021·Granted Jul 4, 2023·5 cites·30 claims
- 0284US12043632B26-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitorsAJAX THERAPEUTICS INC·Filed 2021·Granted Jul 23, 2024·1 cites·35 claims
- 0373US2024254125A16-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitorsAJAX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0471US11970494B26-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitorsAJAX THERAPEUTICS INC·Filed 2022·Granted Apr 30, 2024·0 cites·30 claims
- 0570US12275717B26-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitorsAJAX THERAPEUTICS INC·Filed 2023·Granted Apr 15, 2025·0 cites·29 claims
- 0668US12162881B2Forms and compositions of inhibitors of JAK2AJAX THERAPEUTICS INC·Filed 2022·Granted Dec 10, 2024·0 cites·20 claims
- 0765US2024368157A1Forms and compositions of a jak2 inhibitorAJAX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0859US2024116892A1Heterocyclic amide and urea compounds as jak2 inhibitorsAJAX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0956US2026078131A1Pyrrolo-pyridazine inhibitors of jak2AJAX THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →